Mr. Ashish Dasgupta is a seasoned expert in the pharmaceutical industry, with over 40 years of experience in pharmaceutical development, clinical research, regulatory affairs, pharmacovigilance, medical writing, and GxP audits. He has held leadership roles in some of the most prominent pharmaceutical companies, including Ranbaxy, Lambda Therapeutic Research, Jubilant, and PharmaLex. His career has been marked by his ability to lead business strategies, mentor developing organizations, and provide strategic advisory roles to pharmaceutical, biotech, and clinical research organizations (CROs).Currently, Mr. Dasgupta serves as the Chief Business Officer at Trucan Diagnostic, where he is instrumental in revolutionizing cancer detection and ensuring precision therapy through novel methods of detecting cancer and predicting responses to therapies. In addition to his role at Trucan, he is an advisor to Catawba Research, Chief Mentor at Webo Healthtech/Webosphere, and an advisor to Pharmsol, where he continues to lend his expertise to innovative healthcare initiatives.

Previously, Mr. Dasgupta was the Managing Director of India Operations at PharmaLex, and he also served as the Chief Operating Officer at Jubilant Clinsys, where he led operations and business strategies in India and collaborated with global teams in Europe and the U.S. His experience includes directing operations at Lambda Therapeutic Research and serving as Assistant Director at Ranbaxy.Mr. Dasgupta specializes in strategic advisory roles, mentoring, business plan creation, regulatory support, audits, product branding, and market research. He is keen on exploring new business opportunities in the pharmaceutical and healthcare sectors, particularly those that involve innovative or alternative therapies that can have a significant impact on the healthcare system in India.